Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2016 -03-08 till 2016-04-05
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline-conform study under GLP without deviations

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2016
Report date:
2016

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Pigment Additiv FGR
IUPAC Name:
Pigment Additiv FGR
Constituent 2
Chemical structure
Reference substance name:
N-(4-ethoxyphenyl)-3-hydroxy-4-[(2,4,5-trichlorophenyl)azo]naphthalene-2-carboxamide
EC Number:
225-691-8
EC Name:
N-(4-ethoxyphenyl)-3-hydroxy-4-[(2,4,5-trichlorophenyl)azo]naphthalene-2-carboxamide
Cas Number:
5012-29-3
Molecular formula:
C25H18Cl3N3O3
IUPAC Name:
N-(4-ethoxyphenyl)-3-hydroxy-4-[(2,4,5-trichlorophenyl)diazenyl]-2-naphthamide
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
Identification: Pigment Additiv FGR
Batch: FB3212.013
CAS-No.: 5012-29-3
EINECS / EC-No.: 225-691-8
Purity: 94.51% (w/w), dose calculation was not be adjusted to purity
Appearance: Brown powder
Expiry Date: 10.05.2020 (Statement of producer)
Storage Conditions: At room temperature
Stability in Solvent: > 72 h in DMSO at room temperature
> 72 h in 1,2-propylene glycol at room temperature
Certificate of Analysis: AZ 577/Toxd2, dated 11. December 2015

Method

Species / strain
Species / strain / cell type:
other: TA 1535, TA 1537, TA 98, TA 100, WP2 uvrA
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
with and without
Metabolic activation system:
Phenobarbital/ß-Naphthoflavone induced rat liver S9 (experiment I) and non-induced hamster liver (experiment II)
Test concentrations with justification for top dose:
3, 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate / pre-experiment/experiment I
3, 10, 33; 100; 333; 1000; 2500; and 5000 µg/plate / experiment II
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Best suitable solvent
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
congo red
other: sodium azide; 4-nitro-o-phenylene-diamine; methyl methane sulfonate, 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation;


DURATION
- Preincubation period: 30 minutes
- Exposure duration: 72 hours


NUMBER OF REPLICATIONS: 3 plates


DETERMINATION OF CYTOTOXICITY
A reduction in the number of spontaneous revertants (below the induction factor of 0.5) or a clearing of the bacterial background lawn.

Evaluation criteria:
A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant.
Statistics:
According to the OECD guideline 471, a statistical analysis of the data is not mandatory.

Results and discussion

Test results
Species / strain:
other: TA 1535, TA 1537, TA 98, TA 100, WP2 uvrA
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
exp. I strain WP2 uvrA with S9mix
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: none
- Water solubility: not soluble
- Precipitation:The test item precipitated in the overlay agar in the test tubes from 333 to 5000 µg/plate. Precipitation of the test item in the overlay agar on the incubated agar plates was observed from 333 to 5000 µg/plate. The undissolved particles had no influence on the data recording.
- Other confounding effects:
COMPARISON WITH HISTORICAL CONTROL DATA: In experiment II, the data in the negative control of strains TA 1535 with S9 mix and TA1537 with S9 mix were slightly above our historical control range. Since this deviation is rather small, this effect is considered to be based upon biologically irrelevant fluctuations in the number of colonies.
ADDITIONAL INFORMATION ON CYTOTOXICITY: No toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in all strains with and without metabol¬ic activation in the first experiment. Only in experiment I minor toxic effects were observed in strain WP2 uvrA with S9 mix at 5000 µg/plate.
Remarks on result:
other: other: reverse mutation assay
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Summary Tabellen

Table1            Summary of Experiment I

Study Name: 1755506

Study Code: Envigo 1755506

Experiment: 1755506 VV Plate

Date Plated: 08/03/2016

Assay Conditions:

Date Counted: 11/03/2016

 

Metabolic

Activation

Test

Group

Dose Level

(per plate)

 

Revertant Colony Counts (Mean ±SD)

 

 

 

 

 

 

 

 

 

 

 

 

 

TA 1535

TA 1537

TA 98

TA 100

WP2 uvrA

 

 

 

 

 

 

 

 

 

Without Activation

DMSO

 

 

16 ± 1

9 ± 6

25 ± 7

186 ± 15

51 ± 4

Untreated

 

 

13 ± 4

8 ± 2

22 ± 7

194 ± 15

51 ± 3

Pigment-

3 µg

 

11 ± 2

12 ± 6

29 ± 3

191 ± 7

47 ± 12

Additiv FGR

10 µg

 

13 ± 3

12 ± 4

31 ± 4

197 ± 17

50 ± 16

 

33 µg

 

14 ± 7

9 ± 2

22 ± 2

165 ± 8

45 ± 12

 

100 µg

 

15 ± 2

11 ± 3

30 ± 9

178 ± 13

40 ± 10

 

333 µg

 

16 ± 5P

10 ± 2P

34 ± 7P

178 ± 2P

49 ± 9P

 

1000 µg

 

11 ± 3P

10 ± 1P

26 ± 6P

199 ± 15P

48 ± 7P

 

2500 µg

 

11 ± 3P

7 ± 1P

24 ± 6P

185 ± 12P

45 ± 4P

 

5000 µg

 

13 ± 3P

11 ± 2P

32 ± 10P

199 ± 17P

46 ± 4P

NaN3

10 µg

 

1205 ± 83

 

 

2418 ± 75

 

4-NOPD

10 µg

 

 

 

407 ± 22

 

 

4-NOPD

50 µg

 

 

83 ± 14

 

 

 

MMS

2.0 µL

 

 

 

 

 

1056 ± 53

 

 

 

 

 

 

 

 

 

With Activation

DMSO

 

 

12 ± 4

16 ± 3

39 ± 3

196 ± 33

51 ± 14

Untreated

 

 

14 ± 6

11 ± 3

39 ± 14

175 ± 26

61 ± 10

Pigment-

3 µg

 

11 ± 6

15 ± 2

39 ± 8

203 ± 34

55 ± 1

Additiv FGR

10 µg

 

12 ± 3

13 ± 4

40 ± 12

212 ± 53

49 ± 8

 

33 µg

 

12 ± 5

13 ± 2

43 ± 14

210 ± 51

54 ± 14

 

100 µg

 

14 ± 3

15 ± 1

32 ± 4

193 ± 14

56 ± 4

 

333 µg

 

12 ± 4P

13 ± 3P

31 ± 11P

178 ± 23P

50 ± 3P

 

1000 µg

 

14 ± 3P

13 ± 1P

40 ± 3P

176 ± 7P

57 ± 14P

 

2500 µg

 

9 ± 1P

15 ± 2P

31 ± 7P

186 ± 24P

64 ± 2P

 

5000 µg

 

11 ± 5P

9 ± 4P

32 ± 5P

192 ± 19P

22 ± 5P M

2-AA

2.5 µg

 

539 ± 19

92 ± 13

4980 ± 327

3152 ± 55

 

2-AA

10.0 µg

 

 

 

 

 

476 ± 25

 

 

 

 

 

 

 

 

 

 

Key to Positive Controls

Key to Plate Postfix Codes

 

 

NaN3

2-AA

4-NOPD

MMS

sodium azide

2-aminoanthracene

4-nitro-o-phenylene-diamine

methyl methane sulfonate                              

P

M

Precipitate

Manual count

 

 

 

Table2            Summary of Experiment II

Study Name: 1755506

Study Code: Envigo 1755506

Experiment: 1755506 HV2 Pre

Date Plated: 31/03/2016

Assay Conditions:

Date Counted: 05/04/2016

 

Metabolic

Activation

Test

Group

Dose Level

(per plate)

 

Revertant Colony Counts (Mean ±SD)

 

 

 

 

 

 

 

 

 

 

 

 

 

TA 1535

TA 1537

TA 98

TA 100

WP2 uvrA

 

 

 

 

 

 

 

 

 

Without Activation

DMSO

 

 

12 ± 2

11 ± 3

28 ± 10

151 ± 15

38 ± 6

Untreated

 

 

13 ± 2

8 ± 2

26 ± 9

182 ± 28

51 ± 4

Pigment-

3 µg

 

12 ± 1

11 ± 2

32 ± 8

141 ± 4

42 ± 4

Additiv FGR

10 µg

 

11 ± 4

13 ± 2

29 ± 4

148 ± 15

44 ± 1

 

33 µg

 

12 ± 5

10 ± 1

27 ± 5

141 ± 17

42 ± 2

 

100 µg

 

11 ± 2

11 ± 3

24 ± 4

138 ± 21

38 ± 6

 

333 µg

 

12 ± 1P

11 ± 1P

23 ± 6P

153 ± 17P

41 ± 1P

 

1000 µg

 

14 ± 2P

10 ± 2P

25 ± 11P

158 ± 12P

37 ± 4P

 

2500 µg

 

11 ± 2P

8 ± 1P

20 ± 3P

153 ± 17P

39 ± 8P

 

5000 µg

 

12 ± 4P

6 ± 1P

21 ± 4P

116 ± 17P

43 ± 4P

NaN3

10 µg

 

1211 ± 42

 

 

2161 ± 107

 

4-NOPD

10 µg

 

 

 

487 ± 52

 

 

4-NOPD

50 µg

 

 

80 ± 11

 

 

 

MMS

2 µL

 

 

 

 

 

981 ± 56

 

 

 

 

 

 

 

 

 

With Activation

DMSO

 

 

21 ± 4

24 ± 6

51 ± 7

112 ± 9

66 ± 15

Untreated

 

 

27 ± 8

30 ± 4

53 ± 5

175 ± 10

72 ± 11

Pigment-

3 µg

 

25 ± 7

27 ± 4

56 ± 10

109 ± 3

60 ± 7

Additiv FGR

10 µg

 

27 ± 7

18 ± 2

54 ± 7

127 ± 6

68 ± 11

 

33 µg

 

29 ± 9

18 ± 4

45 ± 8

132 ± 8

68 ± 4

 

100 µg

 

30 ± 4

23 ± 3

58 ± 13

138 ± 12

67 ± 6

 

333 µg

 

27 ± 4P

29 ± 3P M

59 ± 7P

134 ± 18P

61 ± 6P

 

1000 µg

 

18 ± 4P

22 ± 3P M

55 ± 2P

110 ± 4P

65 ± 11P

 

2500 µg

 

16 ± 1P

21 ± 5P M

52 ± 10P

101 ± 7P

63 ± 5P

 

5000 µg

 

15 ± 2P

19 ± 5P M

31 ± 4P

94 ± 1P

48 ± 4P

2-AA

2.5 µg

 

 

 

 

1592 ± 269

 

2-AA

2.5 µg

 

328 ± 45

149 ± 7

 

 

 

2-AA

10 µg

 

 

 

 

 

953 ± 63

Congo red

500 µg

 

 

 

434 ± 119

 

 

 

 

 

 

 

 

 

 

 

 

Key to Positive Controls

Key to Plate Postfix Codes

 

 

NaN3

2-AA

4-NOPD

Congo red

MMS

sodium azide

2-aminoanthracene

4-nitro-o-phenylene-diamine

Congo red

methyl methane sulfonate

P

M

Precipitate

Manual count

 

 

Applicant's summary and conclusion

Conclusions:
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used with and without rat and hamster S9.
Executive summary:

Discussion von Bericht

This study was performed to investigate the potential of Pigment-Additiv FGR to induce gene muta­tions according to the plate incorporation test (experiment I) with and without rat S9 mix and the pre-incubation test (experiment II) with and without hamster S9 mix using theSalmonella typhimuriumstrains TA 1535, TA 1537, TA 98, TA 100, and theEscherichia colistrain WP2 uvrA.

 

The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration and the controls were tested in triplicate. The test item was tested at the following concentrations in both experiments:

3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate

The test item precipitated in the overlay agar in the test tubes from 333 to 5000 µg/plate. Precipitation of the test item in the overlay agar on the incubated agar plates was observed from 333 to 5000 µg/plate. The undissolved particles had no influence on the data recording.

The plates incubated with the test item showed normal back­ground growth up to 5000 µg/plate with and without S9 mix in all strains used.

Minor toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), were observed in strain WP2 uvrA with S9 mix at 5000 µg/plate in experiment I. No toxic effects occurred in the remaining strains with and without metabolic activation in experiment I and II.

 

No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with Pigment-Additiv FGR at any concentration level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowled­ged border of biological relevance.

 

Appropriate reference mutagens were used as positive controls. They showed a distinct in­crease in induced revertant colonies.

In experiment II, the data in the negative control of strains TA 1535 with S9 mix and TA1537 with S9 mix were slightly above our historical control range. Since this deviation is rather small, this effect is considered to be based upon biologically irrelevant fluctuations in the number of colonies.